Related Experiment Video
Updated: Mar 20, 2026

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
Published on: April 7, 2017
Mesenchymal to Epithelial Transition Induced by Reprogramming Factors Attenuates the Malignancy of Cancer Cells
Mikiro Takaishi1, Masahito Tarutani1, Junji Takeda2
1Department of Dermatology, Kochi Medical School, Kochi University, Nankoku, Japan.
Abstract:
Epithelial to mesenchymal transition (EMT) is a biological process of metastatic cancer. However, an effective anticancer therapy that directly targets the EMT program has not yet been discovered. Recent studies have indicated that mesenchymal to epithelial transition (MET), the reverse phenomenon of EMT, is observed in fibroblasts during the generation of induced pluripotent stem cells. In the present study, we investigated the effects of reprogramming factors (RFs) on squamous cell carcinoma (SCC) cells. RFs-introduced cancer cells (RICs) demonstrated the enhanced epithelial characteristics in morphology with altered expression of mRNA and microRNAs. The motility and invasive activities of RICs in vitro were significantly reduced. Furthermore, xenografts of RICs exhibited no lymph node metastasis, whereas metastasis was detected in parental SCC-inoculated mice. Thus, we concluded that RICs regained epithelial properties through MET and showed reduced cancer malignancy in vitro and in vivo. Therefore, the understanding of the MET process in cancer cells by introduction of RFs may lead to the designing of a novel anticancer strategy.
Insights
Reprogramming factors induce mesenchymal to epithelial transition (MET) in cancer cells, reducing their malignancy and metastasis. This MET process offers a potential new strategy for developing novel anticancer therapies targeting metastatic cancer.
Area of Science:
- Oncology
- Stem Cell Biology
- Cancer Biology
Background:
- Epithelial to mesenchymal transition (EMT) drives cancer metastasis, but effective therapies targeting this process are lacking.
- Mesenchymal to epithelial transition (MET), the reverse of EMT, is observed in induced pluripotent stem cell generation.
- Understanding MET in cancer could reveal new therapeutic strategies.
Purpose of the Study:
- To investigate the effects of reprogramming factors (RFs) on squamous cell carcinoma (SCC) cells.
- To determine if inducing MET in cancer cells can reduce their malignant potential.
- To explore RFs as a potential therapeutic strategy against metastatic cancer.
Main Methods:
- Introduction of reprogramming factors (RFs) into SCC cells to create RFs-introduced cancer cells (RICs).
- Assessment of morphological and molecular changes (mRNA, microRNAs) in RICs.
- In vitro evaluation of RICs' motility and invasive activities.
- In vivo study using xenografts to assess lymph node metastasis in mice inoculated with RICs versus parental SCC cells.
Main Results:
- RICs exhibited enhanced epithelial characteristics and altered gene/microRNA expression.
- Motility and invasive activities of RICs were significantly reduced in vitro.
- RIC xenografts showed no lymph node metastasis, unlike parental SCC xenografts.
- RICs demonstrated a reversal of malignant phenotypes through MET.
Conclusions:
- Inducing MET in SCC cells via RFs effectively reduces cancer cell malignancy and metastatic potential in vitro and in vivo.
- The MET process in cancer cells, facilitated by RFs, represents a promising avenue for novel anticancer therapy development.
- Targeting MET offers a potential strategy to combat metastatic cancer by reverting cells to a less aggressive epithelial state.
Related Concept Videos
Somatic to iPS Cell Reprogramming
Forced Transdifferentiation
Artificial...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Cadherins in Tissue Organization
Cell Sorting During Development
Cell sorting plays an...
Methods of Nuclear Reprogramming
Abnormal Proliferation

